Verdict: Justified

Key finding: The fastest grower in the group: revenue +83% to $5.83B and adjusted EPS $3.30 (+109%), both above the top of guidance, with the 2026 outlook raised to $21.0B (from $20.5B). The stock ran +25.0% in two days to $308.21 on 10/28, within 1% of the $310 price of its ~$3B share offering in August. It then fell back to $265.53 (-13.8%), near the $264.31 gap-day open.

Scorecard

Ticker Rev last Q ($M) Rev YoY last Q Rev YoY prior Q Gross margin (last Q, trend) Op margin EPS last Q vs yr ago P/S Mkt cap 1-mo price %
CLS 5,829.7 +82.5% +62.4% 11.0% (from 13.0%) 7.9% 3.26 vs 2.28 1.69 $30.9B -26.5%
FLEX 8,491.0 +24.8% +20.6% 9.6% (from 9.0%) 4.9% 0.70 vs 0.52 1.11 $34.4B -21.4%
JBL 10,616.0 +28.6% +11.8% 9.4% (from 9.5%) 5.7% 3.76 vs 1.99 0.84 $30.2B -4.9%
SANM 3,464.0 +69.7% +102.3% 10.5% (from 8.9%) 6.4% 2.12 vs 1.26 0.72 $9.1B -23.0%

EPS = GAAP from our data. SANM row is its June quarter.

CLS is the growth and margin leader of the contract-manufacturing (EMS) group: revenue +82.5% (accelerating from +62.4%) and op margin 7.9% vs FLEX 4.9%, JBL 5.7% and SANM 6.4%.
- It has the highest P/S of the four (1.69 vs 0.72-1.11).
- Gross margin slipped (13.0% to 11.0%) as volume grows faster than pricing.

Move

Catalyst

Q3 2026, released after the close on 10/26:
- Revenue ~$5.83B (+83%); adjusted EPS $3.30 (+109%), both above the high end of guidance.
- 2026 outlook: revenue $21.0B (was $20.5B; FactSet consensus $20.62B); adjusted EPS ~$11.55 (was $11.30).
- The free-cash-flow outlook changed because of working-capital investment "to support the accelerating growth in 2027."
- Investor and Analyst Day on 10/27: long-range targets not found in search (unknown).

Sector

Risks

Judgement

Justified for the report: a beat above the top of guidance, a raise, and 83% growth.
- But the tape rejected the rally: it stalled under the $310 offering price and gave back about two-thirds of the gain in two sessions.

The business is strong; the stock is in a downtrend with supply overhead.

Sources